WHITNEY HALL: Open Payments
NPI 1124437330 · LICKING, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 31 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $392 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $161 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| ABBVIE INC. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Exact Sciences Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Organogenesis Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: CAPLYTA, BREZTRI, Cologuard Collection Kit, REXULTI, VRAYLAR, ABILIFY MAINTENA, FARXIGA, QULIPTA.
Industry payments across MO — which companies pay providers there.
